458 related articles for article (PubMed ID: 24580040)
1. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
2. The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
[TBL] [Abstract][Full Text] [Related]
3. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
4. Novel Therapies on Primary Biliary Cirrhosis.
Czul F; Levy C
Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
[TBL] [Abstract][Full Text] [Related]
5. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
6. Geoepidemiology and changing mortality in primary biliary cholangitis.
Floreani A; Tanaka A; Bowlus C; Gershwin ME
J Gastroenterol; 2017 Jun; 52(6):655-662. PubMed ID: 28365879
[TBL] [Abstract][Full Text] [Related]
7. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
Bowlus CL; Kenney JT; Rice G; Navarro R
J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid.
Parés A
Dig Dis; 2015; 33 Suppl 2():125-33. PubMed ID: 26642350
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of primary biliary cirrhosis.
Ali AH; Carey EJ; Lindor KD
Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
[TBL] [Abstract][Full Text] [Related]
10. Advances in pharmacotherapy for primary biliary cirrhosis.
Mousa HS; Lleo A; Invernizzi P; Bowlus CL; Gershwin ME
Expert Opin Pharmacother; 2015 Apr; 16(5):633-43. PubMed ID: 25543678
[TBL] [Abstract][Full Text] [Related]
11. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis and bile acids.
Corpechot C
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888
[TBL] [Abstract][Full Text] [Related]
13. Primary biliary cirrhosis: therapeutic advances.
Czul F; Peyton A; Levy C
Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
[TBL] [Abstract][Full Text] [Related]
14. Current Treatment Options for Primary Biliary Cholangitis.
Wong KA; Bahar R; Liu CH; Bowlus CL
Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
[TBL] [Abstract][Full Text] [Related]
15. [New name and new treatments for primary biliary cholangitits].
Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
[TBL] [Abstract][Full Text] [Related]
16. FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Alawad AS; Levy C
Dig Dis Sci; 2016 Dec; 61(12):3395-3404. PubMed ID: 27734248
[No Abstract] [Full Text] [Related]
17. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of cholestatic liver diseases.
Paumgartner G
J Dig Dis; 2010 Jun; 11(3):119-25. PubMed ID: 20579215
[TBL] [Abstract][Full Text] [Related]
19. Novel and emerging therapies for cholestatic liver diseases.
Goldstein J; Levy C
Liver Int; 2018 Sep; 38(9):1520-1535. PubMed ID: 29758112
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary cirrhosis. Is (and how much of) the pathology preventible?
Bar-Dayan Y; Gershwin ME; Levi Y; Amital H; Shoenfeld Y
Immunol Res; 1998; 18(2):117-23. PubMed ID: 9844830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]